Caligan Partners LP

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    new york, NY
  • CIK
    0001727492
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

14

$394.88M
LQDA, VRNA, EX9, EOLS
13F-HR
Feb 14, 2025
000142050625000624

12

$315.47M
LQDA, VRNA, EX9, EOLS
13F-HR
Nov 14, 2024
000142050624002574

13

$428.00M
LQDA, ALIM, ANIK, EX9
13F-HR
Aug 14, 2024
000181455424000010

12

$378.31M
LQDA, ALIM, ANIK, EOLS
13F-HR
May 13, 2024
000172749224000006

11

$296.52M
LQDA, ALIM, ANIK, EX9
13F-HR
Feb 14, 2024
000172749224000002

13

$217.76M
LQDA, ALIM, INTERCEPT PHARMACEUTICALS IN, FLB
13F-HR
Nov 14, 2023
000172749223000011

13

$177.81M
LQDA, ANIK, EX9, FLB
13F-HR
Aug 14, 2023
000172749223000009

11

$143.38M
LQDA, ANIK, FLB, EX9
13F-HR
May 15, 2023
000181455423000002

11

$120.16M
LQDA, ANIK, EOLS, ADMA
RESTATEMENT
May 15, 2023
000181455423000005
Caligan Partners Lp 13F Filings